Effect of Haridradi tail in Acne and Pigmentatio

Phase 4

Completed

• Conditions: Health Condition 1: L810- Postinflammatory hyperpigmentation

• Registration Number: CTRI/2022/01/039493
• Lead Sponsor: Ms Ozone Pharmaceuticals Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-05-31
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

Patients of either sex having mild to moderate facial Acne and mild to moderate acne induced PIH in clinical features.

ïâ??· Patients of age between 18 - 45 years.

ïâ??· Willing to take part in study and signing consent form

Exclusion Criteria

1. With Present History of Skin Disease e.g. Psoriasis, Dermatitis, Vitiligo etc. related to face.

2. Person suffering from any infective or contagious skin disease

3. Under medication with antibiotics, antifungal and steroid during last one month.

4. Women on Oral contraceptives

5. Patients of known uncontrolled hormonal disease.

6. Any kind of diagnosed hereditary skin disorder.

7. Patient who had undergone any type of skin treatment like laser therapy in last 6 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified